Previously, our group has reported a tryptophan prenylated peptide, based on the substance P agonist G (SP-G) sequence, which showed enhanced cytotoxicity against SCLC cell lines: H69 and DMS79, compared to the parent SP-G sequence in vitro [11]. This evidence concerns the gene TAC1 and small cell lung carcinoma.